Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Revenue (2024 - 2025)

Historic Revenue for Kairos Pharma (KAPA) over the last 2 years, with Q1 2025 value amounting to $100.0 million.

  • Kairos Pharma's Revenue rose 62510000.0% to $100.0 million in Q1 2025 from the same period last year, while for Jun 2025 it was $99.5 million, marking a year-over-year change of. This contributed to the annual value of $100.0 million for FY2024, which is 23819523.81% up from last year.
  • Latest data reveals that Kairos Pharma reported Revenue of $100.0 million as of Q1 2025, which was up 62510000.0% from -$537000.0 recorded in Q3 2024.
  • Over the past 5 years, Kairos Pharma's Revenue peaked at $100.0 million during Q1 2025, and registered a low of -$537000.0 during Q3 2024.